Related references
Note: Only part of the references are listed.Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features
Fukiko Kawai-Kitahata et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
Pei-Pei Song et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma
Mingjie Yao et al.
ONCOTARGET (2016)
Efficient Genome Editing in Chicken DF-1 Cells Using the CRISPR/Cas9 System
Yichun Bai et al.
G3-GENES GENOMES GENETICS (2016)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
Dan Wang et al.
HUMAN GENE THERAPY (2015)
Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm
Chao Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
1,8-Cineole Ameliorates Steatosis of Pten Liver Specific KO Mice via Akt Inactivation
Soichiro Murata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma
Shan-Long Ding et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
Brandon J. Aubrey et al.
CELL REPORTS (2015)
Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
Giuliana Amaddeo et al.
GUT (2015)
A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
Linghe Xi et al.
GENOME BIOLOGY (2015)
Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
Irene Rapti et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt et al.
CELL (2014)
The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma
Xiaojun Li et al.
JOURNAL OF HEPATOLOGY (2014)
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Wen Xue et al.
NATURE (2014)
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Yasushi Totoki et al.
NATURE GENETICS (2014)
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
Mirko Tarocchi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology
Rafael B. Blasco et al.
CELL REPORTS (2014)
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
Su-Ru Lin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Zhengyan Kan et al.
GENOME RESEARCH (2013)
Identification of Driver Genes in Hepatocellular Carcinoma by Exome Sequencing
Sean P. Cleary et al.
HEPATOLOGY (2013)
Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation
Sarah-Fee Katz et al.
GASTROENTEROLOGY (2012)
Obesity, inflammation, and liver cancer
Beicheng Sun et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Gyoergy Baffy et al.
JOURNAL OF HEPATOLOGY (2012)
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma
Jian Huang et al.
NATURE GENETICS (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis
Suzhen Jiang et al.
PLOS ONE (2012)
Association of TP53 Mutations With Stem Cell-Like Gene Expression and Survival of Patients With Hepatocellular Carcinoma
Hyun Goo Woo et al.
GASTROENTEROLOGY (2011)
Evolution and classification of the CRISPR-Cas systems
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
CRISPR/Cas System and Its Role in Phage-Bacteria Interactions
Helene Deveau et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
CRISPR/Cas, the Immune System of Bacteria and Archaea
Philippe Horvath et al.
SCIENCE (2010)
NASH and HCC
John M. Page et al.
CLINICS IN LIVER DISEASE (2009)
Live-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity
B Stiles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1
A Radu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
TH Hu et al.
CANCER (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Share Paper
